A Study of Unesbulin in Participants With Advanced Leiomyosarcoma (LMS)
Trial details
- Registry ID
- NCT05269355
- Phase
- Phase 2, Phase 3
Drug identity checked against registry records
Also recorded as PTC596
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study of Unesbulin in Participants With Advanced Leiomyosarcoma (LMS)NCT05269355 | PTC Therapeutics | Phase 2, Phase 3 | Terminated | 2024-06-17Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |